BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2550546)

  • 1. Further studies of the role of transforming growth factor-beta in human B cell function.
    Kehrl JH; Taylor AS; Delsing GA; Roberts AB; Sporn MB; Fauci AS
    J Immunol; 1989 Sep; 143(6):1868-74. PubMed ID: 2550546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes.
    Kehrl JH; Roberts AB; Wakefield LM; Jakowlew S; Sporn MB; Fauci AS
    J Immunol; 1986 Dec; 137(12):3855-60. PubMed ID: 2878044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
    Kasid A; Bell GI; Director EP
    J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of transforming growth factor beta 1 receptors and its effects on the growth of EBV-transformed human B cells.
    Kumar A; Rogers T; Maizel A; Sharma S
    J Immunol; 1991 Aug; 147(3):998-1006. PubMed ID: 1713611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor beta in human squamous carcinoma cell lines.
    Hébert CD; Birnbaum LS
    Cancer Res; 1989 Jun; 49(12):3196-202. PubMed ID: 2541899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibition of a human lymphoma cell line: induction of a transforming growth factor-beta-mediated autocrine negative loop by phorbol myristate acetate.
    Sing GK; Ruscetti FW; Beckwith M; Keller JR; Ellingsworth L; Urba WJ; Longo DL
    Cell Growth Differ; 1990 Nov; 1(11):549-57. PubMed ID: 1965139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
    Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
    Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet factor 4 selectively inhibits binding of TGF-beta 1 to the type I TGF-beta 1 receptor.
    Whitson RH; Wong WL; Itakura K
    J Cell Biochem; 1991 Sep; 47(1):31-42. PubMed ID: 1658013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
    Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM
    Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA.
    Kehrl JH; Thevenin C; Rieckmann P; Fauci AS
    J Immunol; 1991 Jun; 146(11):4016-23. PubMed ID: 1903417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta 1 is required for secretion of IgG of all subclasses by LPS-activated murine B cells in vitro.
    Snapper CM; Waegell W; Beernink H; Dasch JR
    J Immunol; 1993 Nov; 151(9):4625-36. PubMed ID: 8409423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-6 and tumor necrosis factor-alpha. Autocrine and paracrine cytokines involved in B cell function.
    Rieckmann P; D'Alessandro F; Nordan RP; Fauci AS; Kehrl JH
    J Immunol; 1991 May; 146(10):3462-8. PubMed ID: 2026875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of transforming growth factor (TGF)-beta 1 on IgA isotype expression. TGF-beta 1 induces a small increase in sIgA+ B cells regardless of the method of B cell activation.
    Ehrhardt RO; Strober W; Harriman GR
    J Immunol; 1992 Jun; 148(12):3830-6. PubMed ID: 1602131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ba fragment of complement factor B inhibits human B lymphocyte proliferation.
    Ambrus JL; Peters MG; Fauci AS; Brown EJ
    J Immunol; 1990 Mar; 144(5):1549-53. PubMed ID: 2307833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtypes of betaglycan and of type I and type II transforming growth factor-beta (TGF-beta) receptors with different affinities for TGF-beta 1 and TGF-beta 2 are exhibited by human placental trophoblast cells.
    Mitchell EJ; Fitz-Gibbon L; O'Connor-McCourt MD
    J Cell Physiol; 1992 Feb; 150(2):334-43. PubMed ID: 1310325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies recognizing transforming growth factor-beta. Bioactivity neutralization and transforming growth factor beta 2 affinity purification.
    Dasch JR; Pace DR; Waegell W; Inenaga D; Ellingsworth L
    J Immunol; 1989 Mar; 142(5):1536-41. PubMed ID: 2537357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a 60-kDa cell surface-associated transforming growth factor-beta binding protein that can interfere with transforming growth factor-beta receptor binding.
    Piek E; Franzén P; Heldin CH; ten Dijke P
    J Cell Physiol; 1997 Dec; 173(3):447-59. PubMed ID: 9369958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling through CD19, Fc receptors or transforming growth factor-beta: each inhibits the activation of resting human B cells differently.
    Barrett TB; Shu GL; Draves KE; Pezzutto A; Clark EA
    Eur J Immunol; 1990 May; 20(5):1053-9. PubMed ID: 1694130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel action of transforming growth factor beta 1 in functioning human pancreatic carcinoid cells.
    Ishizuka J; Beauchamp RD; Sato K; Townsend CM; Thompson JC
    J Cell Physiol; 1993 Jul; 156(1):112-8. PubMed ID: 8391003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunodetection and modulation of cellular growth with antibodies against native transforming growth factor-beta 1.
    Keski-Oja J; Lyons RM; Moses HL
    Cancer Res; 1987 Dec; 47(24 Pt 1):6451-8. PubMed ID: 2890433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.